Key result
Extracellular zinc application normalized diastolic sarcomere length and significantly enhanced relaxation function in isolated cardiomyocytes from a rat model of hyperglycemia.
Why the study?
Does extracellular zinc exposure improve cardiomyocyte contraction-relaxation function in a rat model of hyperglycemia?
Does extracellular zinc exposure improve cardiomyocyte contraction-relaxation function in a rat model of hyperglycemia?
Extracellular zinc ameliorates the detrimental effects of hyperglycemia on cardiomyocyte relaxation and calcium regulation in a hypothyroid rat model.
Does not support zinc supplementation in patients; leaves open mechanistic role in human diastolic dysfunction.
It has been reported previously that diabetic cardiomyopathy can be inhibited or reverted with chronic zinc supplementation. In the current study, we hypothesized that total cardiac calcium and zinc content is altered in early onset diabetes mellitus characterized in part as hyperglycemia (HG) and that exposure of zinc ion (Zn2+) to isolated cardiomyocytes would enhance contraction-relaxation function in HG more so than in nonHG controls. To better control for differential cardiac myosin isoform expression as occurs in rodents after β-islet cell necrosis, hypothyroidism was induced in 16 rats resulting in 100% β-myosin heavy chain expression in the heart. β-Islet cell necrosis was induced in half of the rats by streptozocin administration. After 6 wks of HG, both HG and nonHG controls rats demonstrated similar myofilament performance measured as thin filament calcium sensitivity, native thin filament velocity in the myosin motility assay and contractile velocity and power. Extracellular Zn2+ reduced cardiomyocyte contractile function in both groups, but enhanced relaxation function significantly in the HG group compared to controls. Most notably, a reduction in diastolic sarcomere length with increasing pacing frequencies, i.e., incomplete relaxation, was more pronounced in the HG compared to controls, but was normalized with extracellular Zn2+ application. This is a novel finding implicating that the detrimental effect of HG on cardiomyocyte Ca2+ regulation can be amelioration by Zn2+. Among the many post-translational modifications examined, only phosphorylation of ryanodine receptor (RyR) at S-2808 was significantly higher in HG compared to nonHG. We did not find in our hypothyroid rats any differentiating effects of HG on myofibrillar protein phosphorylation, lysine acetylation, O-linked N-acetylglucosamine and advanced glycated end-products, which are often implicated as complicating factors in cardiac performance due to HG. Our results suggest that the relaxing effects of Zn2+ on cardiomyocyte function are more pronounced in the HG state due an insulin-dependent effect of enhancing removal of cytosolic Ca2+ via SERCA2a or NCX or by reducing Ca2+ influx via L-type channel or Ca2+ leak through the RyR. Investigations into the effects of Zn2+ on these mechanisms are now underway.
No takes yet. Share an insight, caveat, or question.
Yi et al. (2012) studied Hyperglycemia (Diabetic Cardiomyopathy model) (n=16). Extracellular Zinc (Zn2+) vs. No zinc exposure (non-hyperglycemic controls) was evaluated on Cardiomyocyte relaxation function (diastolic sarcomere length). Extracellular zinc application normalized diastolic sarcomere length and significantly enhanced relaxation function in isolated cardiomyocytes from a rat model of hyperglycemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: